BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22561842)

  • 1. Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0.
    Van Hemelrijck M; Wigertz A; Sandin F; Garmo H; Hellström K; Fransson P; Widmark A; Lambe M; Adolfsson J; Varenhorst E; Johansson JE; Stattin P;
    Int J Epidemiol; 2013 Aug; 42(4):956-67. PubMed ID: 22561842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCBaSe Sweden: a register-based resource for prostate cancer research.
    Hagel E; Garmo H; Bill-Axelson A; Bratt O; Johansson JE; Adolfsson J; Lambe M; Stattin P
    Scand J Urol Nephrol; 2009; 43(5):342-9. PubMed ID: 19921977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden.
    Bill-Axelson A; Garmo H; Lambe M; Bratt O; Adolfsson J; Nyberg U; Steineck G; Stattin P
    Eur Urol; 2010 Mar; 57(3):390-5. PubMed ID: 19914773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of data quality in the National Prostate Cancer Register of Sweden.
    Tomic K; Sandin F; Wigertz A; Robinson D; Lambe M; Stattin P
    Eur J Cancer; 2015 Jan; 51(1):101-11. PubMed ID: 25465187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
    Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
    J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capture rate and representativity of The National Prostate Cancer Register of Sweden.
    Tomic K; Berglund A; Robinson D; Hjälm-Eriksson M; Carlsson S; Lambe M; Stattin P
    Acta Oncol; 2015 Feb; 54(2):158-63. PubMed ID: 25034349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden.
    Van Hemelrijck M; Garmo H; Holmberg L; Stattin P; Adolfsson J
    Eur Urol; 2012 Apr; 61(4):690-700. PubMed ID: 21945719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
    Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
    Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.
    Berglund A; Garmo H; Robinson D; Tishelman C; Holmberg L; Bratt O; Adolfsson J; Stattin P; Lambe M
    Eur J Cancer; 2012 Jan; 48(1):75-84. PubMed ID: 21852113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
    Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P;
    Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden.
    Tomic K; Westerberg M; Robinson D; Garmo H; Stattin P
    Acta Oncol; 2016 Dec; 55(12):1461-1466. PubMed ID: 27749139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
    Varenhorst E; Garmo H; Holmberg L; Adolfsson J; Damber JE; Hellström M; Hugosson J; Lundgren R; Stattin P; Törnblom M; Johansson JE
    Scand J Urol Nephrol; 2005; 39(2):117-23. PubMed ID: 16019764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cancers before and after prostate cancer diagnosis.
    Van Hemelrijck M; Drevin L; Holmberg L; Garmo H; Adolfsson J; Stattin P
    Cancer; 2012 Dec; 118(24):6207-16. PubMed ID: 22674346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
    Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
    J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.
    Ladjevardi S; Berglund A; Varenhorst E; Bratt O; Widmark A; Sandblom G
    BJU Int; 2013 Mar; 111(3):381-8. PubMed ID: 22758210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe Sweden.
    Bill-Axelson A; Garmo H; Nyberg U; Lambe M; Bratt O; Stattin P; Adolfsson J; Steineck G
    Eur J Cancer; 2011 Sep; 47(14):2195-201. PubMed ID: 21612913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden.
    Franck Lissbrant I; Hjälm Eriksson M; Lambe M; Törnblom M; Stattin P
    Scand J Urol; 2020 Jun; 54(3):227-234. PubMed ID: 32363988
    [No Abstract]   [Full Text] [Related]  

  • 19. Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden.
    Nugin H; Folkvaljon Y; Damber JE; Adolfsson J; Robinson D; Stattin P
    Scand J Urol; 2018 Aug; 52(4):277-284. PubMed ID: 30362868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of a population-based cancer register in Sweden--an assessment of data reproducibility in the South-East Region Prostate Cancer Register.
    Sandblom G; Dufmats M; Olsson M; Varenhorst E
    Scand J Urol Nephrol; 2003; 37(2):112-9. PubMed ID: 12745718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.